Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells

BACKGROUND: Hypoxia is as an indicator of poor treatment outcome. Consistently, hypoxic HCT116 colorectal cancer cells are resistant to oxaliplatin, although the mechanistic basis is unclear. This study sought to investigate the relative contribution of HIF-1 (hypoxia-inducible factor-1)-mediated ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, D L, Williams, K J, Cowen, R L, Barathova, M, Eustace, A J, Brittain-Dissont, S, Tilby, M J, Pearson, D G, Ottley, C J, Stratford, I J, Dive, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768443/
https://www.ncbi.nlm.nih.gov/pubmed/19755992
http://dx.doi.org/10.1038/sj.bjc.6605311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768443/
https://www.ncbi.nlm.nih.gov/pubmed/19755992
http://dx.doi.org/10.1038/sj.bjc.6605311

Ejemplares similares